Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Additional filters

Article Language

Species

Sex

Age

Other

Search Results

311 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Publication Date timeline is not available.
Page 1
The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) is associated with schizophrenia and modulates verbal memory and the acoustic startle response.
Lennertz L, Quednow BB, Schuhmacher A, Petrovsky N, Frommann I, Schulze-Rauschenbach S, Landsberg MW, Steinbrecher A, Höfels S, Pukrop R, Klosterkötter J, Franke PE, Wölwer W, Gaebel W, Häfner H, Maier W, Wagner M, Mössner R. Lennertz L, et al. Among authors: klosterkotter j. Int J Neuropsychopharmacol. 2012 Oct;15(9):1205-15. doi: 10.1017/S1461145711001623. Epub 2011 Nov 14. Int J Neuropsychopharmacol. 2012. PMID: 22078257 Free article.
A coding variant of the novel serotonin receptor subunit 5-HT3E influences sustained attention in schizophrenia patients.
Lennertz L, Wagner M, Frommann I, Schulze-Rauschenbach S, Schuhmacher A, Kühn KU, Pukrop R, Klosterkötter J, Wölwer W, Gaebel W, Rietschel M, Häfner H, Maier W, Mössner R. Lennertz L, et al. Among authors: klosterkotter j. Eur Neuropsychopharmacol. 2010 Jun;20(6):414-20. doi: 10.1016/j.euroneuro.2010.02.012. Epub 2010 Mar 30. Eur Neuropsychopharmacol. 2010. PMID: 20356718
A promoter variant of SHANK1 affects auditory working memory in schizophrenia patients and in subjects clinically at risk for psychosis.
Lennertz L, Wagner M, Wölwer W, Schuhmacher A, Frommann I, Berning J, Schulze-Rauschenbach S, Landsberg MW, Steinbrecher A, Alexander M, Franke PE, Pukrop R, Ruhrmann S, Bechdolf A, Gaebel W, Klosterkötter J, Häfner H, Maier W, Mössner R. Lennertz L, et al. Among authors: klosterkotter j. Eur Arch Psychiatry Clin Neurosci. 2012 Mar;262(2):117-24. doi: 10.1007/s00406-011-0233-3. Epub 2011 Sep 7. Eur Arch Psychiatry Clin Neurosci. 2012. PMID: 21901269
The functional coding variant Asn107Ile of the neuropeptide S receptor gene (NPSR1) influences age at onset of obsessive-compulsive disorder.
Lennertz L, Franke PE, Grabe HJ, Rampacher F, Schulze-Rauschenbach S, Guttenthaler V, Ruhrmann S, Pukrop R, Klosterkötter J, Falkai P, Maier W, Wagner M, Mössner R. Lennertz L, et al. Among authors: klosterkotter j. Int J Neuropsychopharmacol. 2013 Oct;16(9):1951-8. doi: 10.1017/S1461145713000382. Epub 2013 May 17. Int J Neuropsychopharmacol. 2013. PMID: 23680103 Free article.
5-HT3 receptor influences the washing phenotype and visual organization in obsessive-compulsive disorder supporting 5-HT3 receptor antagonists as novel treatment option.
Lennertz L, Wagner M, Grabe HJ, Franke PE, Guttenthaler V, Rampacher F, Schulze-Rauschenbach S, Vogeley A, Benninghoff J, Ruhrmann S, Pukrop R, Klosterkötter J, Falkai P, Maier W, Mössner R. Lennertz L, et al. Among authors: klosterkotter j. Eur Neuropsychopharmacol. 2014 Jan;24(1):86-94. doi: 10.1016/j.euroneuro.2013.07.003. Epub 2013 Aug 6. Eur Neuropsychopharmacol. 2014. PMID: 23928294
Short-term treatment with risperidone or haloperidol in first-episode schizophrenia: 8-week results of a randomized controlled trial within the German Research Network on Schizophrenia.
Möller HJ, Riedel M, Jäger M, Wickelmaier F, Maier W, Kühn KU, Buchkremer G, Heuser I, Klosterkötter J, Gastpar M, Braus DF, Schlösser R, Schneider F, Ohmann C, Riesbeck M, Gaebel W. Möller HJ, et al. Among authors: klosterkotter j. Int J Neuropsychopharmacol. 2008 Nov;11(7):985-97. doi: 10.1017/S1461145708008791. Epub 2008 May 9. Int J Neuropsychopharmacol. 2008. PMID: 18466670 Free article. Clinical Trial.
Antisaccade performance is related to genetic loading for schizophrenia.
Petrovsky N, Weiss-Motz F, Schulze-Rauschenbach S, Lemke M, Hornung P, Ruhrmann S, Klosterkötter J, Maier W, Ettinger U, Wagner M. Petrovsky N, et al. Among authors: klosterkotter j. J Psychiatr Res. 2009 Jan;43(3):291-7. doi: 10.1016/j.jpsychires.2008.05.005. Epub 2008 Jun 27. J Psychiatr Res. 2009. PMID: 18585739 Clinical Trial.
Auditory P300 in individuals clinically at risk for psychosis.
Frommann I, Brinkmeyer J, Ruhrmann S, Hack E, Brockhaus-Dumke A, Bechdolf A, Wölwer W, Klosterkötter J, Maier W, Wagner M. Frommann I, et al. Among authors: klosterkotter j. Int J Psychophysiol. 2008 Dec;70(3):192-205. doi: 10.1016/j.ijpsycho.2008.07.003. Epub 2008 Jul 22. Int J Psychophysiol. 2008. PMID: 18700155
DAOA/G72 predicts the progression of prodromal syndromes to first episode psychosis.
Mössner R, Schuhmacher A, Wagner M, Quednow BB, Frommann I, Kühn KU, Schwab SG, Rietschel M, Falkai P, Wölwer W, Ruhrmann S, Bechdolf A, Gaebel W, Klosterkötter J, Maier W. Mössner R, et al. Among authors: klosterkotter j. Eur Arch Psychiatry Clin Neurosci. 2010 Apr;260(3):209-15. doi: 10.1007/s00406-009-0044-y. Epub 2009 Sep 10. Eur Arch Psychiatry Clin Neurosci. 2010. PMID: 19763662 Free PMC article.
Neuropsychological profiles in different at-risk states of psychosis: executive control impairment in the early--and additional memory dysfunction in the late--prodromal state.
Frommann I, Pukrop R, Brinkmeyer J, Bechdolf A, Ruhrmann S, Berning J, Decker P, Riedel M, Möller HJ, Wölwer W, Gaebel W, Klosterkötter J, Maier W, Wagner M. Frommann I, et al. Among authors: klosterkotter j. Schizophr Bull. 2011 Jul;37(4):861-73. doi: 10.1093/schbul/sbp155. Epub 2010 Jan 6. Schizophr Bull. 2011. PMID: 20053865 Free PMC article.
311 results